| abstract |
A composition for nasal administration to animals, including humans. Applicants' composition includes lysozyme in combination with zinc. In certain embodiments, the composition further includes one or more anthelmentic compounds. A method to treat animals, including humans, having a pulmonary bacterial infection by delivering a therapeutically effective amount of lysozyme to the animal's nasal pharynx. A method to treat animals, including humans, having a viral infection by delivering a therapeutically effective amount of zinc to the animal's nasal pharynx. In certain embodiments, the method further includes delivering lysozyme to the animal's nasal pharynx. |